Oct 19, 2022 / 10:15PM GMT
Operator
Thank you for standing by, and welcome to the Telix Pharmaceuticals Third Quarter 2022 Results Call. (Operator Instructions)
I would now like to hand the conference over to Ms. Kyahn Williamson. Please go ahead.
Kyahn Williamson - Telix Pharmaceuticals Limited - SVP of Corporate Communications & IR
Good morning. Thank you so much, Ashley. As mentioned, I'm Kyahn Williamson. I'm the Senior Vice President of Investor Relations and Corporate Communications at Telix. And I'm pleased to welcome today my colleagues speaking on the call, Dr. Christian Behrenbruch, our Group CEO and Managing Director; and Darren Smith, our Group Chief Financial Officer.
So today, we will be discussing the quarterly results, which were lodged on the ASX this morning, along with the appendix for free cash flow and activities report. This is the first time we've hosted a webcast on our quarterly results, and we thought it was fitting to do so now that we are in a commercial stage and given the level of interest in the progress.
If you are joining via phone,
Q3 2022 Telix Pharmaceuticals Ltd Activities Report Call Transcript
Feb 15, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers